R87.624
Cytologic evidence of malignancy on smear of vagina
Clinical Classification Guidelines
Medical Intelligence & Overview
The ICD-10 code R87.624 refers to the presence of cytologic evidence of malignancy found on a smear test of the vagina. This finding indicates that abnormal cells, which may be cancerous, have been detected during microscopic examination. Such results are crucial in diagnosing and managing potential vaginal cancers and guiding further medical evaluation and treatment.
Causes & Symptoms
Clinical Causes: Development of vaginal carcinoma Presence of high-grade intraepithelial lesions Persistent human papillomavirus (HPV) infection History of certain gynecological cancers Immunosuppression or weakened immune system
Key Symptoms: Abnormal vaginal bleeding, especially after intercourse or between periods Unusual vaginal discharge that may be watery, bloody, or foul-smelling Pelvic or vaginal pain or discomfort A lump or mass in the vaginal area Sensation of pressure or fullness in the pelvic region
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a Pap smear, also known as a Pap test, which collects cells from the vaginal lining for microscopic examination. If abnormal or malignant cells are detected, further testing may include colposcopy, biopsy, or imaging studies to determine the extent and nature of the disease. These procedures help clarify whether the abnormal cells are benign, precancerous, or malignant.
Treatment Protocols: Treatment options depend on the type and stage of the malignancy and may involve a combination of approaches such as local excision, laser therapy, radiation therapy, or surgery. In some cases, chemotherapy might be considered if the cancer has spread. Early detection and intervention are fundamental to improving outcomes and preserving quality of life. Ongoing follow-up is essential to monitor for further abnormal changes and ensure successful management.
Clinical Advice & FAQs
Billing Guidance
Is R87.624 a billable ICD-10 code?
Yes, R87.624 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report R87.624?
Clinical documentation must specify the nature of Cytologic evidence of malignancy on smear of vagina and any associated comorbidities for accurate reporting.
Cite this Clinical Reference